UC Davis

1 stories · following the connections

Business

Capricor Announces Initiation of HOPE-2 Clinical Trial of CAP-1002 for Duchenne Muscular Dystrophy

By Nasdaq OMXApr 30, 2018, 11:01 AM UTC